✦ LIBER ✦

Early Withdrawal of Calcineurin Inhibitors and Rescue Immunosuppression with Sirolimus-Based Therapy in Renal Transplant Recipients with Moderate to Severe Renal Dysfunction

✍ Scribed by R. K. Wali; V. Mohanlal; E. Ramos; S. Blahut; C. Drachenberg; J. Papadimitriou; M. Dinits; A. Joshi; B. Philosophe; C. Foster; C. Cangro; J. Nogueira; M. Cooper; S. T. Bartlett; M. R. Weir

Book ID: 114804397
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 135 KB
Volume: 7
Category: Article
ISSN: 1600-6135
DOI: 10.1111/j.1600-6143.2007.01825.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early steroid withdrawal therapy in rena

Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol

✍ James J Jaber; Paul J Feustel; Ossama Elbahloul; Alexander D Conti; Michael H Ga 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 566 KB

A randomized controlled trial of late co

A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function

✍ Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin

Evaluation of the efficacy and safety of

Evaluation of the efficacy and safety of a slow conversion from calcineurin inhibitor- to sirolimus-based therapies in maintenance renal-transplant patients presenting with moderate renal insufficiency

✍ Nassim Kamar; Luc Frimat; Gilles Blancho; Philippe Wolff; Michel Delahousse; Lio 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 482 KB

Observation of Efficacy and Safety of Co

Observation of Efficacy and Safety of Converting the Calcineurin Inhibitor to Sirolimus in Renal Transplant Recipients With Chronic Allograft Nephropathy

✍ J. Chen; L. Li; J. Wen; Z. Tang; S. Ji; G. Sha; Z. Cheng; Q. Sun; D. Cheng; Z. L 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 469 KB

56 Safety and Efficacy of Conversion to

56 Safety and Efficacy of Conversion to Sirolimus vs Continued Calcineurin Inhibitor Use in Cardiac Transplant Recipients with Renal Insufficiency

✍ A. Zuckermann; A. Keogh; M.G. Crespo-Leiro; D. Mancini; F. Gonzalez Vilchez; L. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 167 KB

An open-label, pilot study evaluating th

An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency

✍ V Ram Peddi; Stephen Jensik; Mark Pescovitz; John Pirsch; Scott H Adler; J Richa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB